This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

ASCP Corner

Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 2: Methodological Considerations

Christoph U. Correll, MD

Published: September 17, 2007

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

In last month’s ASCP Corner, I discussed some of the challenges and recent developments regarding the available evidence base for the use of antipsychotics and mood stabilizers in children and adolescents. 1 In this month’s column, I will focus on some of the pertinent clinical psychopharmacology trials design issues that are relevant to the collection of data in children and adolescents who are in need of antipsychotic or mood stabilizer treatment.

While it is clear that studying psychotropic medication effects in children and adolescents is crucial, it is also a difficult task.’ ‹’ ‹

Volume: 68

Quick Links:

Continue Reading…

Subscribe to read the entire article


Buy this Article as a PDF